by Sasha Whitaker | Apr 19, 2023 | Client Spotlights, FDA Announcements, FDA EUA News, News, Press Releases, Regulatory News
Biotoxtech, the No. 1 non-clinical CRO in Korea, and its affiliates (BTT Group) announce that they have signed a business agreement with CSSi LifeSciences, an American CRO, to strengthen new drug development support services. Based on both companies’ accumulated...
Recent Comments